| Literature DB >> 35805648 |
Klára Novotová1, Dagmar Pavlů1, Dominika Dvořáčková1, Anna Arnal-Gómez2,3, Gemma Victoria Espí-López2,4.
Abstract
Walking as physiological training is reported to be an effective activity in order to beneficially influence and slow the onset of aging in healthy elderly people. However, insufficient evidence exists on how walking influences lung function in seniors. In our study, we aim to evaluate the effect of different types of walking on lung function in healthy seniors. The PubMed, Web of Science, Scopus and EBSCO Essentials databases were searched, while the methodological quality was assessed by the RoB2 tool. A total of seven studies (RCTs) published between 2002-2022 that met the eligibility criteria were analysed in this review. All participants were older adults without any specific associated disease, aged 60 and above. The interventions included structured physical activity; a high/moderate exercise program; long-term regular walking; walking as a part of functional movement training; walking sideways, backward and forward as a part of aerobic training; fast walking; Stepper walking; walking on a treadmill combined with incentive spirometry; and Nordic walking. Overall, most of the mentioned types of walking led to improved lung function in healthy elderly subjects. However, the prescribed Stepper walking program did not improve lung function in healthy seniors.Entities:
Keywords: FEV1; FVC; aerobic training; elderly; lung function; older adults; spirometry; walking
Mesh:
Year: 2022 PMID: 35805648 PMCID: PMC9265471 DOI: 10.3390/ijerph19137995
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
The PRISMA statement.
| Database | Keywords | Total Number of Results | Number of Articles in English Published between 2002–2022 |
|---|---|---|---|
| Web of Science | ALL = (elderly) OR ALL = (seniors) OR ALL = (aged) OR ALL = (“older adults”) AND ALL = (walking) OR ALL = (“aerobic training”) AND AB = (spirometry) OR AB = (FVC) OR AB = (FEV1) OR AB = (“lung function”) AND ALL = (“randomized controlled trial”) OR ALL = (RCT) OR ALL = (randomized) | 248 | 202 |
| PubMed | (elderly) OR (seniors) OR (aged) OR (“older adults”) AND (walking) OR (“aerobic training”) AND (spirometry [Title/Abstract]) OR (FVC[Title/Abstract]) OR (FEV1[Title/Abstract]) OR (“lung function”[Title/Abstract]) AND (“randomized controlled trial”) OR (RCT) OR (randomized) | 390 | 290 |
| Scopus | ALL (elderly) OR ALL (seniors) OR ALL (aged) OR ALL (“older adults”) AND ALL (walking) OR ALL (“aerobic training”) AND ABS (spirometry) OR ABS (fvc) OR ABD (fev1) OR ABS (“lung function”) AND (ALL (“randomized controlled trial”) OR ALL (rct) OR ALL (randomized) | 1652 | 1279 |
| EBSCO Essentials | “AND elderly OR seniors OR aged OR “older adults” AllFields AND walking OR “aerobic training” AllFields AND spirometry OR FVC OR FEV1 OR “lung function” Abstract AND “randomized controlled trial” OR RCT OR randomized AllFields“ | 669 | 634 |
Abbreviations: FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s; RCT: randomized controlled trial.
Eligibility criteria for study selection.
| PICOS | Inclusion Criteria | Exclusion Criteria |
|---|---|---|
| Population | Studies including | Studies not including seniors aged 60 and above |
| Intervention | Different types of walking | Studies not including different types of walking as intervention |
| Comparator | Studies including a comparison group | NA |
| Measured outcome | Spirometry | Studies not including spirometry |
| Study design | RCT | Cross-over studies, reviews, non-randomized controlled trials, preliminary studies, studies with no control group |
Abbreviations: NA: not applicable; RCT: randomized controlled trial.
Keywords.
| PICOS | Keywords |
|---|---|
| P | (“elderly” OR “seniors” OR “aged” OR “older adults”) |
| I | (“walking” OR “aerobic training”) |
| C | NA |
| O | (“spirometry” OR “FVC“ OR “FEV1” OR “lung function”) |
| S | (randomized controlled “trial” OR “RCT” OR “randomized” |
Abbreviations: NA: not applicable; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s; RCT: randomized controlled trial.
Figure 1Flow diagram illustrating the selection process.
Main characteristics of included studies.
| First Author | Fragoso | Huang | Saygin | Šokeliene | Shim | Kuo | El Kader |
|---|---|---|---|---|---|---|---|
|
| 2016 | 2005 | 2015 | 2011 | 2019 | 2018 | 2013 |
|
| 1635 | 45 | 30 | 41 | 30 | 36 | 40 |
|
| 1098 | not stated | 30 | 30 | not stated | 30 | 20 |
|
| 537 | not stated | 0 | 11 | not stated | 6 | 20 |
|
| 78.7 (5.2) | 85.3 (2.5) | 74.28 (8.78) I.G. | 65 | 75.33 | 68.93 | 67.27 |
|
| Structured physical activity | High/ | Long-term regular walking | Nordic walking | Aerobic training with rhythmic functional movement | Prescribed Stepper walking program | Aerobic Exercise Training |
|
| 24–42 months | 10 weeks | 6 months | 12 weeks | 8 weeks | 8 weeks | 3 months |
|
| Control group | Control group | Control group | Control group | Control group | Control group | Control group |
|
| FEV1, maximal inspiratory pressure (MIP), exacerbation of obstructive airways disease (EOAD) | FVC, FEV1, diastolic blood pressure, systolic blood pressure, resting heart rate, flexibility, reaction time, height, weight | FVC, Sit and Reach test, handgrip strength, Get Up and Go test, physical activity level, body fat percentage, height, weight | VC, aerobic endurance, calf endurance, Sit and Reach test, weight, height, waist/hip ratio | FVC, FEV1, maximal voluntary ventilation (MVV), The functional movement screen (FMS), quality of life (SF-36) | FVC, FEV1, 6MWT, fatigue intensity, extremity muscle power, BMI, MMSE, Barthel index, IADL scale, GDS-15, waist/hip ratio, body fat %, handgrip/body weight ratio | VC, FEV1, MVV, PImax., PEmax., inspiratory muscle endurance |
|
| RCT | RCT | RCT | RCT | RCT | RCT | RCT |
Figure 2Risk of bias summary of the included studies.